FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Fredrick Wigley

Research Profile

Disorders

Procedures

Concepts & Ideas

Anatomy

Fingers
Skin

Chemicals & Drugs

Phenomena

Vital Capacity

Physiology

Pulmonary Diffusing Capacity

Co-author Network

Publications

TOP 3
Ami Shah; Fredrick M Wigley
My approach to the treatment of scleroderma.
Roozbeh Sharif; Filemon K Tan; Fredrick M Wigley; Jun Ying; Sandeep K Agarwal; Frank C Arnett; Lara Bossini-Castillo; Hilda T Draeger; Daniel E Furst; Emilio B Gonzalez; Olga Y Gorlova; Laura K Hummers; Dinesh Khanna; Javier Martin; MD Mayes; John D Reveille; Ami Shah; Shervin Assassi
IRF5 polymorphism predicts prognosis in patients with systemic sclerosis.
Andrea Fava; Sharon R Ghazarian; Laura K Hummers; Fredrick M Wigley; Peter K Wung; Natalie R Daya; Francesco Boin
Efficacy of Rho kinase inhibitor fasudil in secondary Raynaud's phenomenon.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Fredrick Wigley (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Ami Shah; Fredrick M Wigley
My approach to the treatment of scleroderma.
Mayo Clinic proceedings. Mayo Clinic 2013;88(4):377-93.
2012: Roozbeh Sharif; Filemon K Tan; Fredrick M Wigley; Jun Ying; Sandeep K Agarwal; Frank C Arnett; Lara Bossini-Castillo; Hilda T Draeger; Daniel E Furst; Emilio B Gonzalez; Olga Y Gorlova; Laura K Hummers; Dinesh Khanna; Javier Martin; MD Mayes; John D Reveille; Ami Shah; Shervin Assassi
IRF5 polymorphism predicts prognosis in patients with systemic sclerosis.
Annals of the rheumatic diseases 2012;71(7):1197-202.
2012: Andrea Fava; Sharon R Ghazarian; Laura K Hummers; Fredrick M Wigley; Peter K Wung; Natalie R Daya; Francesco Boin
Efficacy of Rho kinase inhibitor fasudil in secondary Raynaud's phenomenon.
Arthritis care & research 2012;64(6):925-9.
2012: Elizabeth N Le; Noelle S Sherber; JACQUELINE JUNKINS-HOPKINS; Fredrick M Wigley
Nodular/keloidal scleroderma: acquired collagenous nodules in systemic sclerosis.
The Journal of rheumatology 2012;39(3):660-1.
2012: Keith M Sullivan; Jacob M van Laar; Fredrick M Wigley; Christopher P Denton; Daniel E Furst
Haemopoietic stem-cell transplantation for systemic sclerosis.
Lancet 2012;379(9812):219; author reply 219-20.
2012: Chris Cheadle; JINSHUI FAN; Reda E Girgis; Dmitry N Grigoryev; Sangjucta Barkataki; Kathleen C Barnes; Alan E Berger; Meher Boorgula; Laura K Hummers; Roger Johns; Stephen C Mathai; A MICHAEL MCDEVITT; Yumiko Sugawara; Tonya N Watkins; Fredrick M Wigley; Ari L Zaiman; Paul M Hassoun
Erythroid-specific transcriptional changes in PBMCs from pulmonary hypertension patients.
PloS one 2012;7(4):e34951.
2011: Olga Gorlova; Pravitt Gourh; Peter K Gregersen; Ariane Herrick; Roger Hesselstrand; Monique Hinchcliff; Anna-Maria Hoffmann-Vold; Fredric Houssiau; Laura K Hummers; Nicolas Hunzelmann; Annet Italiaander; Bobby P C Koeleman; Alexander Kreuter; Annette T Lee; Benedicte A Lie; Claudio Lunardi; Rajan Madhok; Sandeep Agarwal; Paolo Airo; Behrooz Z Alizadeh; Christopher I Amos; Frank C Arnett; Shervin Assassi; Lorenzo Beretta; Jasper C Broen; Patricia Carreira; Meng May Chee; Marieke J H Coenen; Elfride de Baere; Filip de Keyser; Christopher P Denton; Lina-Marcela Diaz-Gallo; Vicente Fonollosa; Carmen Fonseca; Paloma García de la Peña; Francisco J García-Hernández; María F González-Escribano; Miguel A González-Gay; Jose-Ezequiel Martin; Maureen D Mayes; J Lee Nelson; Annika Nordin; Roel A Ophoff; Norberto Ortego-Centeno; Leonid Padyukov; Oyvind Palm; Timothy R D J Radstake; Gabriella Riemekasten; Blanca Rueda; Annemie J Schuerwegh; Raffaella Scorza; Paul G Shiels; Carmen P Simeon; Vanessa Smith; Filemon K Tan; Maria Teruel; Jacob van Laar; Piet L C M van Riel; Ruben van 't Slot; Marie Vanthuyne; John Varga; Madelon C Vonk; Alexandre E Voskuyl; Rene Westhovens; Fredrick M Wigley; Torsten Witte; Jane Worthington; Jun Ying; Javier Martin
Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy.
PLoS genetics 2011;7(7):e1002178.
2011: Rebecca L Manno; Fredrick M Wigley; Allan C Gelber; Laura K Hummers
Late-age onset systemic sclerosis.
The Journal of rheumatology 2011;38(7):1317-25.
2011: Elizabeth N Le; Fredrick M Wigley; Ami Shah; Francesco Boin; Laura K Hummers
Long-term experience of mycophenolate mofetil for treatment of diffuse cutaneous systemic sclerosis.
Annals of the rheumatic diseases 2011;70(6):1104-7.
2011: Ruby Knafo; Jennifer Haythornthwaite; Leslie Heinberg; Fredrick M Wigley; Brett D Thombs
The association of body image dissatisfaction and pain with reduced sexual function in women with systemic sclerosis.
Rheumatology (Oxford, England) 2011;50(6):1125-30.
2011: Amy Elizabeth Dezern; Michelle Petri; Daniel B Drachman; Douglas A Kerr; Edward R Hammond; Jeanne Kowalski; Hua-Ling Tsai; David M Loeb; Grant J Anhalt; Fredrick M Wigley; Richard J Jones; Robert A Brodsky
High-dose cyclophosphamide without stem cell rescue in 207 patients with aplastic anemia and other autoimmune diseases.
Medicine 2011;90(2):89-98.
2011: SHIKHA MITTOO; Fredrick M Wigley; Robert Wise; Adrianne Woods; HUIQING XIAO; Laura K Hummers
Long term effects of cyclophosphamide treatment on lung function and survival in scleroderma patients with interstitial lung disease.
The open rheumatology journal 2011;5():1-6.
2011: Marco Matucci-Cerinic; Christopher P Denton; Daniel E Furst; Maureen D Mayes; Vivien M Hsu; Patrick Carpentier; Fredrick M Wigley; Carol M Black; Barri J Fessler; Peter A Merkel; Janet E Pope; Nadera Sweiss; Mittie K Doyle; Bernhard Hellmich; Thomas A Medsger; Adele Morganti; Fabrice Kramer; Joseph H Korn; James R Seibold
Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial.
Annals of the rheumatic diseases 2011;70(1):32-8.
2010: Lisa R Jewett; Marie Hudson; Jennifer Haythornthwaite; Leslie Heinberg; Fredrick M Wigley; Murray Baron; Brett D Thombs
Development and validation of the brief-satisfaction with appearance scale for systemic sclerosis.
Arthritis care & research 2010;62(12):1779-86.
2010: Ami Shah; Antony Rosen; Laura K Hummers; Fredrick M Wigley; Livia Casciola-Rosen
Close temporal relationship between onset of cancer and scleroderma in patients with RNA polymerase I/III antibodies.
Arthritis and rheumatism 2010;62(9):2787-95.
2010: Arantza Campo; Stephen C Mathai; Jérôme Le Pavec; Ari L Zaiman; Laura K Hummers; Danielle Boyce; Traci Housten; Hunter C Champion; Noah Lechtzin; Fredrick M Wigley; Reda E Girgis; Paul M Hassoun
Hemodynamic predictors of survival in scleroderma-related pulmonary arterial hypertension.
American journal of respiratory and critical care medicine 2010;182(2):252-60.
2010: Jerome Avouac; Ulrich Walker; Alan Tyndall; André Kahan; Marco Matucci-Cerinic; Yannick Allanore; I Miniati; A Muller; F Iannone; O Distler; R Becvar; S Sierakowsky; O Kowal-Bielecka; P Coelho; jean paul cabane; M Cutolo; Y Shoenfeld; G Valentini; J Rovensky; G Riemekasten; P Vlachoyiannopoulos; R Caporali; S Jiri; M Inanc; I Zimmermann Gorska; P Carreira; S Novak; L Czirjak; F Oliveira Ramos; M Jendro; C Chizzolini; E J Kucharz; J Richter; F Cozzi; B Rozman; C M Mallia; A Gabrielli; D Farge; H P Kiener; D Schöffel; P Airo; F Wollheim; D Martinovic; F Trotta; S Jablonska; K Reich; S Bombardieri; P Siakka; R Pellerito; L M Bambara; J Morovic-Vergles; C Denton; R Hinrichs; F Van den Hoogen; N Damjanov; I Kötter; V Ortiz; S Heitmann; D Krasowska; M Seidel; P Hasler; J M Van Laar; J P Kaltwasser; I Foeldvari; A Juan Mas; G Bajocchi; M Wislowska; J A Pereira Da Silva; S Jacobsen; M Worm; W Graniger; A Kuhn; A Stankovic; R Cossutta; M Majdan; L Damjanovska Rajcevska; M Tikly; E L Nasonov; K Steinbrink; A Herrick; U Müller-Ladner; A Dinc; R Scorza; K Sondergaard; F Indiveri; H Nielsen; Z Szekanecz; R M Silver; M Antivalle; I B Espinosa; P García de la Pena Lefebvre; O Midtvedt; D Launay; F Valesini; P Tuvik; R M Ionescu; N Del Papa; S Pinto; Fredrick M Wigley; C Mihai; M Sinziana Capranu; C Sunderkötter; J B Jun; S Alhasani; J H Distler; E Ton; T Soukup; J Seibold; S Zeni; P Nash; L Mouthon; F De Keyser; M T Duruöz; F P Cantatore; G Strauss; C A von Mülhen; M R Pozzi; K Eyerich; J Szechinski; M Keiserman; F A Houssiau; J A Román-Ivorra; B Krummel-Lorenz; M Aringer; R Westhovens; F Bellisai; M Mayer; F Stoeckl; M Uprus; A Volpe; M Buslau; S Yavuz; B Granel; A Valderílio Feijó; F Del Galdo; S Popa; thierry zenone; X Ricardo Machado; M Pileckyte; S Stebbings; A Mathieu; A Tulli; T Tourinho; R Souza; R Acayaba de Toledo; L Stamp; K Solanki; D Veale; J Francisco Marques Neto; G F Bagnato; E Loyo; S Toloza; M Li; W Ahmed Abdel Atty Mohamed; V Cobankara; J Olas; F Salsano; F Oksel; C M Tanaseanu; R Foti; C Ancuta; M Vonk; P Caramashi; L Beretta; A Balbir; A Chiàla; K Pasalic Simic; M Ghio; B Stamenkovic; S Rednic; N Host; R Pellerito; E Hachulla; D E Furst
Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR) database.
The Journal of rheumatology 2010;37(7):1488-501.
2010: Timothy R D J Radstake; Olga Gorlova; Blanca Rueda; Jose-Ezequiel Martin; Behrooz Z Alizadeh; Rogelio Palomino-Morales; Marieke J Coenen; Madelon C Vonk; Alexandre E Voskuyl; Annemie J Schuerwegh; Jasper C Broen; Piet L C M van Riel; Ruben van 't Slot; Annet Italiaander; Roel A Ophoff; Gabriela Riemekasten; Nico Hunzelmann; Carmen P Simeon; Norberto Ortego-Centeno; Miguel A González-Gay; María Francisca González-Escribano; Paolo Airo; Jaap van Laar; Ariane Herrick; Jane Worthington; Roger Hesselstrand; Vanessa Smith; Filip de Keyser; Fredric Houssiau; Meng May Chee; Rajan Madhok; Paul Shiels; Rene Westhovens; Alexander Kreuter; Hans Kiener; Elfride de Baere; Torsten Witte; Leonid Padykov; Lars Klareskog; Lorenzo Beretta; Rafaella Scorza; Benedicte A Lie; Anna-Maria Hoffmann-Vold; Patricia Carreira; John Varga; Monique Hinchcliff; Peter K Gregersen; Annette T Lee; Jun Ying; Younghun Han; Shih-Feng Weng; Christopher I Amos; Fredrick M Wigley; Laura K Hummers; J Lee Nelson; Sandeep K Agarwal; Shervin Assassi; Pravitt Gourh; Filemon K Tan; Bobby P C Koeleman; Frank C Arnett; Javier Martin; Maureen D Mayes
Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus.
Nature genetics 2010;42(5):426-9.
2010: Bart Loeys; E E Gerber; Douglas L Riegert-Johnson; S Iqbal; P Whiteman; V McConnell; C R Chillakuri; D Macaya; P J Coucke; Anne De Paepe; Daniel P Judge; Fredrick M Wigley; Elaine C Davis; H J Mardon; P Handford; D R Keene; Lynn Y Sakai; Harry C Dietz
Mutations in fibrillin-1 cause congenital scleroderma: stiff skin syndrome.
Science translational medicine 2010;2(23):23ra20.
2010: Elizabeth N Le; Julie A Freischlag; Paul J Christo; Avneesh Chhabra; Fredrick M Wigley
Thoracic outlet syndrome secondary to localized scleroderma treated with botulinum toxin injection.
Arthritis care & research 2010;62(3):430-3.
2010: Ami Shah; Fredrick M Wigley; Laura K Hummers
Telangiectases in scleroderma: a potential clinical marker of pulmonary arterial hypertension.
The Journal of rheumatology 2010;37(1):98-104.
2010: Stephen C Mathai; M Bueso; Laura K Hummers; D Boyce; Noah Lechtzin; J Le Pavec; Arantza Campo; Hunter C Champion; T Housten; Paul R Forfia; Ari L Zaiman; Fredrick M Wigley; Reda E Girgis; Paul M Hassoun
Disproportionate elevation of N-terminal pro-brain natriuretic peptide in scleroderma-related pulmonary hypertension.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2010;35(1):95-104.
2009: Reda E Girgis; Stephen C Mathai; Fredrick M Wigley; Paul M Hassoun
Survival in systemic sclerosis-related pulmonary arterial hypertension in the modern treatment era.
American journal of respiratory and critical care medicine 2009;180(12):1280; author reply 1280-1.
2009: David B Badesch; Michael D McGoon; Robyn J Barst; Victor F Tapson; Lewis J Rubin; Fredrick M Wigley; Kenneth M Kral; Ibrahim H Raphiou; Glenn D Crater
Longterm survival among patients with scleroderma-associated pulmonary arterial hypertension treated with intravenous epoprostenol.
The Journal of rheumatology 2009;36(10):2244-9.
2009: Ruby Knafo; Brett D Thombs; Lisa Jewett; Marie Hudson; Fredrick M Wigley; Jennifer Haythornthwaite
(Not) talking about sex: a systematic comparison of sexual impairment in women with systemic sclerosis and other chronic disease samples.
Rheumatology (Oxford, England) 2009;48(10):1300-3.
2009: Philip Song; Christopher D Gocke; Fredrick M Wigley; Francesco Boin
Resolution of pansclerotic morphea after treatment with antithymocyte globulin.
Nature reviews. Rheumatology 2009;5(9):513-6.
2009: N S Sherber; Francesco Boin; Laura K Hummers; Fredrick M Wigley
The "tank top sign": a unique pattern of skin fibrosis seen in pansclerotic morphea.
Annals of the rheumatic diseases 2009;68(9):1511-2.
2009: Francesco Boin; Stefano Franchini; ELIZABETH COLANTUONI; Antony Rosen; Fredrick M Wigley; Livia Casciola-Rosen
Independent association of anti-beta(2)-glycoprotein I antibodies with macrovascular disease and mortality in scleroderma patients.
Arthritis and rheumatism 2009;60(8):2480-9.
2009: Francesco Boin; Fredrick M Wigley
Connective tissue diseases: Immunosuppressive therapy in SSc: what is the target?
Nature reviews. Rheumatology 2009;5(7):357-8.
2009: Noëlle S Sherber; Fredrick M Wigley; Stephen A Paget
Diffuse fasciitis with eosinophilia developing after local irradiation for breast cancer.
Clinical rheumatology 2009;28(6):729-32.
2009: Fredrick M Wigley
Vascular disease in scleroderma.
Clinical reviews in allergy & immunology 2009;36(2-3):150-75.
2009: Otylia Kowal-Bielecka; R Landewé; J Avouac; S Chwiesko; I Miniati; L Czirjak; P Clements; C Denton; D Farge; K Fligelstone; I Földvari; D E Furst; U Müller-Ladner; J Seibold; Richard M Silver; K Takehara; B Garay Toth; A Tyndall; G Valentini; F van den Hoogen; Fredrick M Wigley; F Zulian; Marco Matucci-Cerinic
EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR).
Annals of the rheumatic diseases 2009;68(5):620-8.
2009: J Avouac; Otylia Kowal-Bielecka; R Landewe; S Chwiesko; I Miniati; L Czirjak; P Clements; C Denton; D Farge; K Fligelstone; I Földvari; D E Furst; U Müller-Ladner; J Seibold; Richard M Silver; K Takehara; B Garay Toth; A Tyndall; G Valentini; F van den Hoogen; Fredrick M Wigley; F Zulian; M Matucci-Cerinic
European League Against Rheumatism (EULAR) Scleroderma Trial and Research group (EUSTAR) recommendations for the treatment of systemic sclerosis: methods of elaboration and results of systematic literature research.
Annals of the rheumatic diseases 2009;68(5):629-34.
2009: Dinesh Khanna; Philip J Clements; Daniel E Furst; Joseph H Korn; Michael H Ellman; Naomi F Rothfield; Fredrick M Wigley; Larry W Moreland; Richard M Silver; Youn H Kim; Virginia D Steen; Gary S Firestein; Arthur F Kavanaugh; Michael Weisman; MD Mayes; David Collier; Mary E Csuka; Robert W Simms; Peter A Merkel; Thomas A Medsger; Martin E Sanders; Paul Maranian; James R Seibold
Recombinant human relaxin in the treatment of systemic sclerosis with diffuse cutaneous involvement: a randomized, double-blind, placebo-controlled trial.
Arthritis and rheumatism 2009;60(4):1102-11.
2009: Nick Loizos; Leah Lariccia; Jami Weiner; Heather Griffith; Francesco Boin; Laura K Hummers; Fredrick M Wigley; Paul Kussie
Lack of detection of agonist activity by antibodies to platelet-derived growth factor receptor alpha in a subset of normal and systemic sclerosis patient sera.
Arthritis and rheumatism 2009;60(4):1145-51.
2009: Lorinda Chung; Lee Shapiro; David Fiorentino; Murray Baron; Joseph Shanahan; Sangeeta D Sule; Vivien Hsu; Naomi Rothfield; Virginia Steen; Richard W Martin; Edwin Smith; Maureen Mayes; Robert Simms; Janet Pope; Bashar Kahaleh; M E Csuka; Barry Gruber; David Collier; Nadera Sweiss; Adam Gilbert; Frederick J Dechow; Jeffrey Gregory; Fredrick M Wigley
MQX-503, a novel formulation of nitroglycerin, improves the severity of Raynaud's phenomenon: a randomized, controlled trial.
Arthritis and rheumatism 2009;60(3):870-7.
2009: Laura K Hummers; Amy Hall; Fredrick M Wigley; Michael Simons
Abnormalities in the regulators of angiogenesis in patients with scleroderma.
The Journal of rheumatology 2009;36(3):576-82.
2009: Stephen C Mathai; Laura K Hummers; Hunter C Champion; Fredrick M Wigley; Ari L Zaiman; Paul M Hassoun; Reda E Girgis
Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: impact of interstitial lung disease.
Arthritis and rheumatism 2009;60(2):569-77.
2009: S B Sandusky; L McGuire; Michael Smith; Fredrick M Wigley; Jennifer Haythornthwaite
Fatigue: an overlooked determinant of physical function in scleroderma.
Rheumatology (Oxford, England) 2009;48(2):165-9.
2008: Arnold E Postlethwaite; Weng Kee Wong; Philip Clements; Soumya Chatterjee; Barri J Fessler; Andrew H Kang; Joseph Korn; MD Mayes; Peter A Merkel; Jerry A Molitor; Larry Moreland; Naomi Rothfield; Robert W Simms; Edwin A Smith; Robert Spiera; Virginia Steen; Kenneth Warrington; Barbara A White; Fredrick M Wigley; Daniel E Furst
A multicenter, randomized, double-blind, placebo-controlled trial of oral type I collagen treatment in patients with diffuse cutaneous systemic sclerosis: I. oral type I collagen does not improve skin in all patients, but may improve skin in late-phase disease.
Arthritis and rheumatism 2008;58(6):1810-22.
2008: Peter K Wung; Matthew R Pipeling; Fredrick M Wigley
"Still" ill?
The American journal of medicine 2008;121(6):491-3.
2008: C V Tehlirian; Laura K Hummers; Barbara A White; Robert A Brodsky; Fredrick M Wigley
High-dose cyclophosphamide without stem cell rescue in scleroderma.
Annals of the rheumatic diseases 2008;67(6):775-81.
2008: Francesco Boin; Umberto De Fanis; Susan J Bartlett; Fredrick M Wigley; Antony Rosen; Vincenzo Casolaro
T cell polarization identifies distinct clinical phenotypes in scleroderma lung disease.
Arthritis and rheumatism 2008;58(4):1165-74.
2008: Dmitry N Grigoryev; Stephen C Mathai; Micah R Fisher; Reda E Girgis; Ari L Zaiman; Traci Housten-Harris; Chris Cheadle; Li Gao; Laura K Hummers; Hunter C Champion; Joe G. N. Garcia; Fredrick M Wigley; Rubin M Tuder; Kathleen C Barnes; Paul M Hassoun
Identification of candidate genes in scleroderma-related pulmonary arterial hypertension.
Translational research : the journal of laboratory and clinical medicine 2008;151(4):197-207.
2008: Ami Shah; Fredrick M Wigley
Often forgotten manifestations of systemic sclerosis.
Rheumatic diseases clinics of North America 2008;34(1):221-38; ix.
2008: Fredrick M Wigley
Systemic sclerosis (scleroderma) is unique among our rheumatic diseases. Preface.
Rheumatic diseases clinics of North America 2008;34(1):xi-xiii.
2008: Marissa Blum; Fredrick M Wigley; Laura K Hummers
Scleromyxedema: a case series highlighting long-term outcomes of treatment with intravenous immunoglobulin (IVIG).
Medicine 2008;87(1):10-20.
2007: T Rinda Soong; Lili A Barouch; Hunter C Champion; Fredrick M Wigley; Marc K Halushka
New clinical and ultrastructural findings in hydroxychloroquine-induced cardiomyopathy--a report of 2 cases.
Human pathology 2007;38(12):1858-63.
2007: SHIKHA MITTOO; Fredrick M Wigley; Robert Wise; HUIQING XIAO; Laura K Hummers
Persistence of abnormal bronchoalveolar lavage findings after cyclophosphamide treatment in scleroderma patients with interstitial lung disease.
Arthritis and rheumatism 2007;56(12):4195-202.
2007: Donald P Tashkin; Robert Elashoff; Philip J Clements; Michael D Roth; Daniel E Furst; Richard M Silver; Jonathan Goldin; Edgar Arriola; Charlton B. Strange; Marcy B Bolster; James R Seibold; David J Riley; Vivien M Hsu; John Varga; Dean E Schraufnagel; Arthur Theodore; Robert Simms; Robert Wise; Fredrick M Wigley; Barbara A White; Virginia Steen; Charles Read; MD Mayes; Ed Parsley; Kamal Mubarak; M Kari Connolly; Jeffrey Golden; Mitchell Olman; Barri Fessler; Naomi Rothfield; Mark Metersky; Dinesh Khanna; Ning Li; Gang Li
Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease.
American journal of respiratory and critical care medicine 2007;176(10):1026-34.
2007: Sheridan Henness; Fredrick M Wigley
Current drug therapy for scleroderma and secondary Raynaud's phenomenon: evidence-based review.
Current opinion in rheumatology 2007;19(6):611-8.
2007: Mary Jo Mulligan-Kehoe; Mary Drinane; Jessica Mollmark; Livia Casciola-Rosen; Laura K Hummers; Amy Hall; Antony Rosen; Fredrick M Wigley; Michael Simons
Antiangiogenic plasma activity in patients with systemic sclerosis.
Arthritis and rheumatism 2007;56(10):3448-58.
2007: Gordon K Lam; Laura K Hummers; Adrianne Woods; Fredrick M Wigley
Efficacy and safety of etanercept in the treatment of scleroderma-associated joint disease.
The Journal of rheumatology 2007;34(7):1636-7.
2007: Dinesh Khanna; Xiaohong Yan; Donald P Tashkin; Daniel E Furst; Robert Elashoff; Michael D Roth; Richard M Silver; Charlton B. Strange; Marcy B Bolster; James R Seibold; David J Riley; Vivien M Hsu; John Varga; Dean E Schraufnagel; Arthur Theodore; Robert Simms; Robert Wise; Fredrick M Wigley; Barbara A White; Virginia Steen; Charles Read; MD Mayes; Ed Parsley; Kamal Mubarak; M Kari Connolly; Jeffrey Golden; Mitchell Olman; Barri Fessler; Naomi Rothfield; Mark Metersky; Philip J Clements
Impact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung disease: results from the scleroderma lung study.
Arthritis and rheumatism 2007;56(5):1676-84.
2007: Leslie J Heinberg; Ian Kudel; Barbara A White; Amy Kwan; Keya Medley; Fredrick M Wigley; Jennifer Haythornthwaite
Assessing body image in patients with systemic sclerosis (scleroderma): validation of the adapted Satisfaction with Appearance Scale.
Body image 2007;4(1):79-86.
2007: Noëlle S Sherber; Fredrick M Wigley; Richard Scher
Autoimmune disorders: nail signs and therapeutic approaches.
Dermatologic therapy 2007;20(1):17-30.
2006: Lionel Schachna; Thomas A Medsger; James H Dauber; Fredrick M Wigley; Neil A Braunstein; Barbara A White; Virginia D Steen; John V Conte; Stephen C Yang; Kenneth R McCurry; Marvin C Borja; David E Plaskon; Jonathan B Orens; Allan C Gelber
Lung transplantation in scleroderma compared with idiopathic pulmonary fibrosis and idiopathic pulmonary arterial hypertension.
Arthritis and rheumatism 2006;54(12):3954-61.
2006: Caroline G.P. Roberts; Laura K Hummers; William J Ravich; Fredrick M Wigley; Grover M Hutchins
A case-control study of the pathology of oesophageal disease in systemic sclerosis (scleroderma).
Gut 2006;55(12):1697-703.
2006: Noelle S Sherber; Fredrick M Wigley; Grant J Anhalt
Bullous pemphigoid in a patient with systemic sclerosis (scleroderma).
The Journal of rheumatology 2006;33(10):2098.
2006: Dinesh Khanna; Daniel E Furst; Ron Hays; Grace S Park; Weng Kee Wong; James R Seibold; MD Mayes; Barbara A White; Fredrick M Wigley; Michael Weisman; Water Barr; Larry Moreland; Thomas A Medsger; Virginia Steen; Richard W Martin; David Collier; Arthur Weinstein; Edward Lally; John Varga; Steven R Weiner; Brian Andrews; Micha Abeles; Philip J Clements
Minimally important difference in diffuse systemic sclerosis: results from the D-penicillamine study.
Annals of the rheumatic diseases 2006;65(10):1325-9.
2006: Micah R Fisher; Stephen C Mathai; Hunter C Champion; Reda E Girgis; Traci Housten-Harris; Laura K Hummers; Jerry Krishnan; Fredrick M Wigley; Paul M Hassoun
Clinical differences between idiopathic and scleroderma-related pulmonary hypertension.
Arthritis and rheumatism 2006;54(9):3043-50.
2006: Robert R Edwards; Layne Goble; Amy Kwan; Ian Kudel; Lynanne McGuire; Leslie J Heinberg; Fredrick M Wigley; Jennifer Haythornthwaite
Catastrophizing, pain, and social adjustment in scleroderma: relationships with educational level.
The Clinical journal of pain 2006;22(7):639-46.
2006: Diane L Kamen; Fredrick M Wigley; Alan N Brown
Antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis in scleroderma--a different kind of renal crisis.
The Journal of rheumatology 2006;33(9):1886-8.
2006: Allan C Gelber; Stanley R Pillemer; B J Baum; Fredrick M Wigley; Laura K Hummers; Steven Morris; Antony Rosen; Livia Casciola-Rosen
Distinct recognition of antibodies to centromere proteins in primary Sjogren's syndrome compared with limited scleroderma.
Annals of the rheumatic diseases 2006;65(8):1028-32.
2006: Donald P Tashkin; Robert Elashoff; Philip J Clements; Jonathan Goldin; Michael D Roth; Daniel E Furst; Edgar Arriola; Richard M Silver; Charlton B. Strange; Marcy B Bolster; James R Seibold; David J Riley; Vivien M Hsu; John Varga; Dean E Schraufnagel; Arthur Theodore; Robert Simms; Robert Wise; Fredrick M Wigley; Barbara A White; Virginia Steen; Charles Read; MD Mayes; Ed Parsley; Kamal Mubarak; M Kari Connolly; Jeffrey Golden; Mitchell Olman; Barri Fessler; Naomi Rothfield; Mark Metersky
Cyclophosphamide versus placebo in scleroderma lung disease.
The New England journal of medicine 2006;354(25):2655-66.
2006: Betty Chang; Lionel Schachna; Barbara A White; Fredrick M Wigley; Robert Wise
Natural history of mild-moderate pulmonary hypertension and the risk factors for severe pulmonary hypertension in scleroderma.
The Journal of rheumatology 2006;33(2):269-74.
2006: Keary A Cope; Steven F Solga; Laura K Hummers; Fredrick M Wigley; Anna Mae Diehl; Terence H Risby
Abnormal exhaled ethane concentrations in scleroderma.
Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals 2006;11(1):70-84.
2005: Francesco Boin; Fredrick M Wigley; Jonathan P Schneck; Mathias Oelke; Antony Rosen
Evaluation of topoisomerase-1-specific CD8+ T-cell response in systemic sclerosis.
Annals of the New York Academy of Sciences 2005;1062():137-45.
2005: Xialin Liu; Shoukang Zhu; Tao Wang; Laura K Hummers; Fredrick M Wigley; Pascal J Goldschmidt-Clermont; Chunming Dong
Paclitaxel modulates TGFbeta signaling in scleroderma skin grafts in immunodeficient mice.
PLoS medicine 2005;2(12):e354.
2005: Francesco Boin; Fredrick M Wigley
Understanding, assessing and treating Raynaud's phenomenon.
Current opinion in rheumatology 2005;17(6):752-60.
2005: Reda E Girgis; Stephen C Mathai; Jerry Krishnan; Fredrick M Wigley; Paul M Hassoun
Long-term outcome of bosentan treatment in idiopathic pulmonary arterial hypertension and pulmonary arterial hypertension associated with the scleroderma spectrum of diseases.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2005;24(10):1626-31.
2005: Thomas Grader-Beck; Fredrick M Wigley
Raynaud's phenomenon in mixed connective tissue disease.
Rheumatic diseases clinics of North America 2005;31(3):465-81, vi.
2005: Fredrick M Wigley; João A C Lima; MD Mayes; David McLain; J Lincoln Chapin; Clive Ward-Able
The prevalence of undiagnosed pulmonary arterial hypertension in subjects with connective tissue disease at the secondary health care level of community-based rheumatologists (the UNCOVER study).
Arthritis and rheumatism 2005;52(7):2125-32.
2005: Dinesh Khanna; Daniel E Furst; Philip J Clements; Grace S Park; Ron Hays; Jeonglim Yoon; Joseph H Korn; Peter A Merkel; Naomi F Rothfield; Fredrick M Wigley; Larry W Moreland; Richard M Silver; Virginia Steen; Michael Weisman; MD Mayes; David H Collier; Thomas A Medsger; James R Seibold
Responsiveness of the SF-36 and the Health Assessment Questionnaire Disability Index in a systemic sclerosis clinical trial.
The Journal of rheumatology 2005;32(5):832-40.
2005: Dinesh Khanna; Philip J Clements; Daniel E Furst; Yun Chon; Robert Elashoff; Michael D Roth; Mildred G Sterz; Joannie Chung; John D FitzGerald; James R Seibold; John Varga; Arthur Theodore; Fredrick M Wigley; Richard M Silver; Virginia Steen; MD Mayes; M Kari Connolly; Barri J Fessler; Naomi F Rothfield; Kamal Mubarak; Jerry Molitor; Donald P Tashkin
Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study.
Arthritis and rheumatism 2005;52(2):592-600.
2004: Robert Wise; Fredrick M Wigley; Barbara A White; Gwen Leatherman; Jianhua Zhong; Holly Krasa; Junichi Kambayashi; Cesare Orlandi; Frank S Czerwiec
Efficacy and tolerability of a selective alpha(2C)-adrenergic receptor blocker in recovery from cold-induced vasospasm in scleroderma patients: a single-center, double-blind, placebo-controlled, randomized crossover study.
Arthritis and rheumatism 2004;50(12):3994-4001.
2004: Philip J Clements; James R Seibold; Daniel E Furst; MD Mayes; Barbara A White; Fredrick M Wigley; Michael D Weisman; Water Barr; Larry Moreland; Thomas A Medsger; Virginia Steen; Richard W Martin; David Collier; Arthur Weinstein; Edward Lally; John Varga; Steven R Weiner; Brian Andrews; Micha Abeles; Weng Kee Wong
High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial: lessons learned.
Seminars in arthritis and rheumatism 2004;33(4):249-63.
2004: Laura K Hummers; Chitra Krishnan; Livia Casciola-Rosen; Antony Rosen; Steven Morris; James A Mahoney; Douglas A Kerr; Fredrick M Wigley
Recurrent transverse myelitis associates with anti-Ro (SSA) autoantibodies.
Neurology 2004;62(1):147-9.
2003: Lisa Christopher-Stine; Fredrick M Wigley
Tumor necrosis factor-alpha antagonists induce lupus-like syndrome in patients with scleroderma overlap/mixed connective tissue disease.
The Journal of rheumatology 2003;30(12):2725-7.
2003: Lionel Schachna; Fredrick M Wigley; Betty Chang; Barbara A White; Robert Wise; Allan C Gelber
Age and risk of pulmonary arterial hypertension in scleroderma.
Chest 2003;124(6):2098-104.
2003: Betty Chang; Fredrick M Wigley; Barbara A White; Robert Wise
Scleroderma patients with combined pulmonary hypertension and interstitial lung disease.
The Journal of rheumatology 2003;30(11):2398-405.
2003: Irina G Luzina; Sergei Atamas; Robert Wise; Fredrick M Wigley; Jung Choi; HUIQING XIAO; Barbara A White
Occurrence of an activated, profibrotic pattern of gene expression in lung CD8+ T cells from scleroderma patients.
Arthritis and rheumatism 2003;48(8):2262-74.
2003: Kane L Schaphorst; Eddie T Chiang; Keri N Jacobs; Ari L Zaiman; Viswanathan Natarajan; Fredrick M Wigley; Joe G. N. Garcia
Role of sphingosine-1 phosphate in the enhancement of endothelial barrier integrity by platelet-released products.
American journal of physiology. Lung cellular and molecular physiology 2003;285(1):L258-67.
2003: Megan E B Clowse; Fredrick M Wigley
Digital necrosis related to carboplatin and gemcitabine therapy in systemic sclerosis.
The Journal of rheumatology 2003;30(6):1341-3.
2003: Laura K Hummers; Fredrick M Wigley
Management of Raynaud's phenomenon and digital ischemic lesions in scleroderma.
Rheumatic diseases clinics of North America 2003;29(2):293-313.
2003: Lisa M Benrud-Larson; Leslie J Heinberg; Christy Boling; Jeffrey Reed; Barbara A White; Fredrick M Wigley; Jennifer Haythornthwaite
Body image dissatisfaction among women with scleroderma: extent and relationship to psychosocial function.
Health psychology : official journal of the Division of Health Psychology, American Psychological Association 2003;22(2):130-9.
2003: Sangeeta D Sule; Fredrick M Wigley
Treatment of scleroderma: an update.
Expert opinion on investigational drugs 2003;12(3):471-82.
2003: Danielle B Ulanet; Fredrick M Wigley; Allan C Gelber; Antony Rosen
Autoantibodies against B23, a nucleolar phosphoprotein, occur in scleroderma and are associated with pulmonary hypertension.
Arthritis and rheumatism 2003;49(1):85-92.
2002: Richard F Macko; Allan C Gelber; Bradford A Young; Mark H Lowitt; Barbara A White; Fredrick M Wigley; Simeon E Goldblum
Increased circulating concentrations of the counteradhesive proteins SPARC and thrombospondin-1 in systemic sclerosis (scleroderma). Relationship to platelet and endothelial cell activation.
The Journal of rheumatology 2002;29(12):2565-70.
2002: Paul J DeMarco; Michael H Weisman; James R Seibold; Daniel E Furst; Weng Kee Wong; Eric L Hurwitz; MD Mayes; Barbara A White; Fredrick M Wigley; Water Barr; Larry Moreland; Thomas A Medsger; Virginia Steen; Richard W Martin; David Collier; Arthur Weinstein; Edward Lally; John Varga; Steven R Weiner; Brian Andrews; Micha Abeles; Philip J Clements
Predictors and outcomes of scleroderma renal crisis: the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial.
Arthritis and rheumatism 2002;46(11):2983-9.
2002: Lionel Schachna; Fredrick M Wigley
Targeting mediators of vascular injury in scleroderma.
Current opinion in rheumatology 2002;14(6):686-93.
2002: Fredrick M Wigley
Clinical practice. Raynaud's Phenomenon.
The New England journal of medicine 2002;347(13):1001-8.
2002: Peter A Merkel; Karen Herlyn; Richard W Martin; Jennifer J Anderson; MD Mayes; Patrice Bell; Joseph H Korn; Robert W Simms; Mary Ellen Csuka; Thomas A Medsger; Naomi F Rothfield; Michael H Ellman; David H Collier; Arthur Weinstein; Daniel E Furst; Sergio A Jiménez; Barbara A White; James R Seibold; Fredrick M Wigley
Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon.
Arthritis and rheumatism 2002;46(9):2410-20.
2002: Lionel Schachna; Fredrick M Wigley; Steven Morris; Allan C Gelber; Antony Rosen; Livia Casciola-Rosen
Recognition of Granzyme B-generated autoantigen fragments in scleroderma patients with ischemic digital loss.
Arthritis and rheumatism 2002;46(7):1873-84.
2002: Adrienne Rencic; Supriya Goyal; Mona Z Mofid; Fredrick M Wigley; H Carlos Nousari
Bullous lesions in scleroderma.
International journal of dermatology 2002;41(6):335-9.
2002: Irina G Luzina; Sergei Atamas; Robert Wise; Fredrick M Wigley; HUIQING XIAO; Barbara A White
Gene expression in bronchoalveolar lavage cells from scleroderma patients.
American journal of respiratory cell and molecular biology 2002;26(5):549-57.
2002: Chunming Dong; Shoukang Zhu; Tao Wang; Woohyun Yoon; Zhiru Li; Rene J Alvarez; Peter ten Dijke; Barbara A White; Fredrick M Wigley; Pascal J Goldschmidt-Clermont
Deficient Smad7 expression: a putative molecular defect in scleroderma.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(6):3908-13.
2002: Lisa M Benrud-Larson; Jennifer Haythornthwaite; Leslie J Heinberg; Christy Boling; Jeffrey Reed; Barbara A White; Fredrick M Wigley
The impact of pain and symptoms of depression in scleroderma.
Pain 2002;95(3):267-75.
2002: Allan C Gelber; Fredrick M Wigley
Disease severity as a predictor of outcome in scleroderma.
Lancet 2002;359(9303):277-9.
2001: Eric L Greidinger; Sean Gaine; Robert Wise; Christy Boling; T Housten-Harris; Fredrick M Wigley
Primary pulmonary hypertension is not associated with scleroderma-like changes in nailfold capillaries.
Chest 2001;120(3):796-800.
2001: Keith M Hull; L Griffith; R W Kuncl; Fredrick M Wigley
A deceptive case of amyloid myopathy: clinical and magnetic resonance imaging features.
Arthritis and rheumatism 2001;44(8):1954-8.
2001: Fredrick M Wigley
When is scleroderma really scleroderma?
The Journal of rheumatology 2001;28(7):1471-3.
2001: Daniel E Furst; Philip J Clements; W K Wong; MD Mayes; Fredrick M Wigley; Barbara A White; Michael Weisman; W Barr; Larry Moreland; R Martin; Thomas A Medsger; Virginia Steen; D Collier; A Weinstein; Edward Lally; J Varga; Steven R Weiner; B Andrews; Micha Abeles; J B Peter; James R Seibold
Effects of the American College of Rheumatology systemic sclerosis trial guidelines on the nature of systemic sclerosis patients entering a clinical trial.
Rheumatology (Oxford, England) 2001;40(6):615-22.
2001: John H Stone; Gary S Hoffman; Peter A Merkel; Yuan-I Min; Misty L Uhlfelder; David B Hellmann; Ulrich Specks; Nancy B Allen; John C Davis; Robert Spiera; L H Calabrese; Fredrick M Wigley; N Maiden; R M Valente; John L Niles; Kenneth H Fye; W Joseph McCune; E William St Clair; Raashid Luqmani
A disease-specific activity index for Wegener's granulomatosis: modification of the Birmingham Vasculitis Activity Score. International Network for the Study of the Systemic Vasculitides (INSSYS).
Arthritis and rheumatism 2001;44(4):912-20.
2001: Philip J Clements; Weng Kee Wong; Eric L Hurwitz; Daniel E Furst; MD Mayes; Barbara A White; Fredrick M Wigley; Michael Weisman; Water Barr; Larry Moreland; Thomas A Medsger; Virginia Steen; Richard W Martin; David Collier; Arthur Weinstein; Edward Lally; John Varga; Steven R Weiner; Brian Andrews; Micha Abeles; James R Seibold
The Disability Index of the Health Assessment Questionnaire is a predictor and correlate of outcome in the high-dose versus low-dose penicillamine in systemic sclerosis trial.
Arthritis and rheumatism 2001;44(3):653-61.
2001: Livia Casciola-Rosen; A F Pluta; Paul H Plotz; A E Cox; Steven Morris; Fredrick M Wigley; Michelle Petri; Allan C Gelber; Antony Rosen
The DNA mismatch repair enzyme PMS1 is a myositis-specific autoantigen.
Arthritis and rheumatism 2001;44(2):389-96.
2001: Fredrick M Wigley
Raynaud's phenomenon is linked to unopposed estrogen replacement therapy in postmenopausal women.
Clinical and experimental rheumatology 2001;19(1):10-1.
2001: Fredrick M Wigley; Sangeeta D Sule
Novel therapy in the treatment of scleroderma.
Expert opinion on investigational drugs 2001;10(1):31-48.
2000: P A Henry; Sergei Atamas; Vladimir V Yurovsky; Irina G Luzina; Fredrick M Wigley; Barbara A White
Diversity and plasticity of the anti-DNA topoisomerase I autoantibody response in scleroderma.
Arthritis and rheumatism 2000;43(12):2733-42.
2000: Philip J Clements; Eric L Hurwitz; Weng Kee Wong; James R Seibold; MD Mayes; Barbara A White; Fredrick M Wigley; Michael Weisman; Water Barr; Larry Moreland; Thomas A Medsger; Virginia Steen; Richard W Martin; David Collier; Arthur Weinstein; Edward Lally; John Varga; Steven R Weiner; Brian Andrews; Micha Abeles; Daniel E Furst
Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: high-dose versus low-dose penicillamine trial.
Arthritis and rheumatism 2000;43(11):2445-54.
2000: Allan C Gelber; Marc C Hochberg; LA Mead; Nae-Yuh Wang; Fredrick M Wigley; Michael J Klag
Joint injury in young adults and risk for subsequent knee and hip osteoarthritis.
Annals of internal medicine 2000;133(5):321-8.
2000: Nicholas Flavahan; Sheila Flavahan; Q Liu; S Wu; W Tidmore; Charles M Wiener; R J Spence; Fredrick M Wigley
Increased alpha2-adrenergic constriction of isolated arterioles in diffuse scleroderma.
Arthritis and rheumatism 2000;43(8):1886-90.
2000: Barbara A White; Wendy C Moore; Fredrick M Wigley; HUIQING XIAO; Robert Wise
Cyclophosphamide is associated with pulmonary function and survival benefit in patients with scleroderma and alveolitis.
Annals of internal medicine 2000;132(12):947-54.
2000: James R Seibold; Joseph H Korn; Robert W Simms; Philip J Clements; Larry W Moreland; MD Mayes; Daniel E Furst; Naomi F Rothfield; Virginia Steen; Michael Weisman; D Collier; Fredrick M Wigley; Peter A Merkel; Mary Ellen Csuka; V Hsu; S Rocco; ME Erikson; JF Hannigan; W S Harkonen; M E Sanders
Recombinant human relaxin in the treatment of scleroderma. A randomized, double-blind, placebo-controlled trial.
Annals of internal medicine 2000;132(11):871-9.
2000: Allan C Gelber; H Carlos Nousari; Fredrick M Wigley
Mycophenolate mofetil in the treatment of severe skin manifestations of dermatomyositis: a series of 4 cases.
The Journal of rheumatology 2000;27(6):1542-5.
2000: David B Badesch; Victor F Tapson; Michael D McGoon; B H Brundage; Lewis J Rubin; Fredrick M Wigley; Stuart Rich; Robyn J Barst; P S Barrett; K M Kral; Maria M Jöbsis; James E Loyd; S Murali; Adaani Frost; Reda E Girgis; Robert Bourge; D D Ralph; C Gregory Elliott; Nicholas S Hill; David Langleben; Robert J Schilz; Vallerie V McLaughlin; Ivan M Robbins; Bertron M Groves; Shelley Shapiro; T A Medsger
Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial.
Annals of internal medicine 2000;132(6):425-34.
2000: Sangeeta D Sule; Fredrick M Wigley
Update on management of scleroderma.
Bulletin on the rheumatic diseases 2000;49(10):1-4.
2000: V Rosas; John V Conte; Stephen C Yang; Sean Gaine; Marvin C Borja; Fredrick M Wigley; Barbara A White; Jonathan B Orens
Lung transplantation and systemic sclerosis.
Annals of transplantation : quarterly of the Polish Transplantation Society 2000;5(3):38-43.
1999: Allan C Gelber; Marc C Hochberg; LA Mead; Nae-Yuh Wang; Fredrick M Wigley; Michael J Klag
Body mass index in young men and the risk of subsequent knee and hip osteoarthritis.
The American journal of medicine 1999;107(6):542-8.
1999: Alan K. Matsumoto; R Moore; Patricia M Alli; Fredrick M Wigley
Three cases of osteonecrosis of the lunate bone of the wrist in scleroderma.
Clinical and experimental rheumatology 1999;17(6):730-2.
1999: Philip J Clements; Weng Kee Wong; Eric L Hurwitz; Daniel E Furst; MD Mayes; Barbara A White; Fredrick M Wigley; Michael Weisman; Water Barr; Larry Moreland; Thomas A Medsger; Virginia Steen; R Martin; David Collier; Arthur Weinstein; Edward Lally; John Varga; S Weiner; Brian Andrews; Micha Abeles; James R Seibold
Correlates of the disability index of the health assessment questionnaire: a measure of functional impairment in systemic sclerosis.
Arthritis and rheumatism 1999;42(11):2372-80.
1999: Uzma J Haque; John H. Yardley; Mark A Talamini; Fredrick M Wigley
Colon stricture and volvulus in a patients with scleroderma.
The Journal of rheumatology 1999;26(10):2268-72.
1999: Shari Miura Ling; Fredrick M Wigley
Raynaud's phenomenon in older adults: diagnostic considerations and management.
Drugs & aging 1999;15(3):183-95.
1999: Philip J Clements; Daniel E Furst; Weng Kee Wong; MD Mayes; Barbara A White; Fredrick M Wigley; Michael H Weisman; Water Barr; L W Moreland; Thomas A Medsger; Virginia Steen; Richard W Martin; David Collier; Arthur Weinstein; Edward Lally; John Varga; S Weiner; Brian Andrews; Micha Abeles; James R Seibold
High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two-year, double-blind, randomized, controlled clinical trial.
Arthritis and rheumatism 1999;42(6):1194-203.
1999: Sergei Atamas; Vladimir V Yurovsky; Robert Wise; Fredrick M Wigley; C J Goter Robinson; P Henry; W J Alms; Barbara A White
Production of type 2 cytokines by CD8+ lung cells is associated with greater decline in pulmonary function in patients with systemic sclerosis.
Arthritis and rheumatism 1999;42(6):1168-78.
1999: Allan C Gelber; Fredrick M Wigley; Rebecca Stallings; Lee R Bone; A V Barker; I Baylor; C W Harris; Martha N Hill; Scott Zeger; David M Levine
Symptoms of Raynaud's phenomenon in an inner-city African-American community: prevalence and self-reported cardiovascular comorbidity.
Journal of clinical epidemiology 1999;52(5):441-6.
1999: Bruce Thompson; N L Geller; Sally Hunsberger; M Frederick; R Hill; Rolfe G Jacob; Edwin A Smith; P Kaufmann; Robert R Freedman; Fredrick M Wigley; Leonard Bielory
Behavioral and pharmacologic interventions: the Raynaud's Treatment Study.
Controlled clinical trials 1999;20(1):52-63.
1999: M Sagar; W M Bowerfind; Fredrick M Wigley
A man with diabetes and a swollen leg.
Lancet 1999;353(9147):116.
1998: Eric L Greidinger; K T Flaherty; Barbara A White; Antony Rosen; Fredrick M Wigley; Robert Wise
African-American race and antibodies to topoisomerase I are associated with increased severity of scleroderma lung disease.
Chest 1998;114(3):801-7.
1998: Fredrick M Wigley; Joseph H Korn; Mary Ellen Csuka; Thomas A Medsger; Naomi F Rothfield; Michael H Ellman; R Martin; David H Collier; Arthur Weinstein; Daniel E Furst; Sergio A Jimenez; MD Mayes; Peter A Merkel; B Gruber; L Kaufman; John Varga; P Bell; J Kern; P Marrott; Barbara A White; Robert W Simms; A C Phillips; James R Seibold
Oral iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis: a multicenter, placebo-controlled, double-blind study.
Arthritis and rheumatism 1998;41(4):670-7.
1998: John H Stone; Fredrick M Wigley
Management of systemic sclerosis: the art and science.
Seminars in cutaneous medicine and surgery 1998;17(1):55-64.
1998: James R Seibold; Philip J Clements; Daniel E Furst; MD Mayes; Deborah A McCloskey; Larry W Moreland; Barbara A White; Fredrick M Wigley; S Rocco; ME Erikson; JF Hannigan; M E Sanders; E P Amento
Safety and pharmacokinetics of recombinant human relaxin in systemic sclerosis.
The Journal of rheumatology 1998;25(2):302-7.
1997: Antony Rosen; Livia Casciola-Rosen; Fredrick M Wigley
Role of metal-catalyzed oxidation reactions in the early pathogenesis of scleroderma.
Current opinion in rheumatology 1997;9(6):538-43.
1997: Livia Casciola-Rosen; Fredrick M Wigley; Antony Rosen
Scleroderma autoantigens are uniquely fragmented by metal-catalyzed oxidation reactions: implications for pathogenesis.
The Journal of experimental medicine 1997;185(1):71-9.
1996: Fredrick M Wigley
Raynaud's phenomenon and other features of scleroderma, including pulmonary hypertension.
Current opinion in rheumatology 1996;8(6):561-8.
1996: Fredrick M Wigley; Nicholas Flavahan
Raynaud's phenomenon.
Rheumatic diseases clinics of North America 1996;22(4):765-81.
1996: Marc C Hochberg; D L Perlmutter; Thomas A Medsger; K Nguyen; Virginia Steen; M H Weisman; Barbara A White; Fredrick M Wigley
Lack of association between augmentation mammoplasty and systemic sclerosis (scleroderma).
Arthritis and rheumatism 1996;39(7):1125-31.
1996: Vladimir V Yurovsky; Fredrick M Wigley; Robert Wise; Barbara A White
Skewing of the CD8+ T-cell repertoire in the lungs of patients with systemic sclerosis.
Human immunology 1996;48(1-2):84-97.
1996: Robert P. Roca; Fredrick M Wigley; Barbara A White
Depressive symptoms associated with scleroderma.
Arthritis and rheumatism 1996;39(6):1035-40.
1996: Fredrick M Wigley
Management of Severe Raynaud's Phenomenon.
Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 1996;2(2):103-11.
1995: Marc C Hochberg; D L Perlmutter; Thomas A Medsger; Virginia Steen; M H Weisman; Barbara A White; Fredrick M Wigley
Prevalence of self-reported physician-diagnosed systemic lupus erythematosus in the USA.
Lupus 1995;4(6):454-6.
1995: Allan C Gelber; Fredrick M Wigley
Treatment of scleroderma.
Current opinion in rheumatology 1995;7(6):551-9.
1995: Marc C Hochberg; R Miller; Fredrick M Wigley
Frequency of augmentation mammoplasty in patients with systemic sclerosis: data from the Johns Hopkins-University of Maryland Scleroderma Center.
Journal of clinical epidemiology 1995;48(4):565-9.
1995: James D Michelson; M Easley; Fredrick M Wigley; David B Hellmann
Posterior tibial tendon dysfunction in rheumatoid arthritis.
Foot & ankle international. / American Orthopaedic Foot and Ankle Society [and] Swiss Foot and Ankle Society 1995;16(3):156-61.
1995: Susan E Whitmore; Fredrick M Wigley; Robert Wise
Acute effect of topical minoxidil on digital blood flow in patients with Raynaud's phenomenon.
The Journal of rheumatology 1995;22(1):50-4.
1994: Fredrick M Wigley
Clinical aspects of systemic and localized scleroderma.
Current opinion in rheumatology 1994;6(6):628-36.
1994: James D Michelson; M Easley; Fredrick M Wigley; David B Hellmann
Foot and ankle problems in rheumatoid arthritis.
Foot & ankle international. / American Orthopaedic Foot and Ankle Society [and] Swiss Foot and Ankle Society 1994;15(11):608-13.
1994: Vladimir V Yurovsky; P A Sutton; Dan H Schulze; Fredrick M Wigley; Robert Wise; R F Howard; Barbara A White
Expansion of selected V delta 1+ gamma delta T cells in systemic sclerosis patients.
Journal of immunology (Baltimore, Md. : 1950) 1994;153(2):881-91.
1994: Fredrick M Wigley; Robert Wise; James R Seibold; D A McCloskey; G Kujala; Thomas A Medsger; Virginia D Steen; John Varga; S Jimenez; MD Mayes; P J Clements; S R Weiner; J Porter; M Ellman; C Wise; L D Kaufman; J Williams; W Dole
Intravenous iloprost infusion in patients with Raynaud phenomenon secondary to systemic sclerosis. A multicenter, placebo-controlled, double-blind study.
Annals of internal medicine 1994;120(3):199-206.
1994: Robert Wise; Fredrick M Wigley
Acute effects of misoprostol on digital circulation in patients with Raynaud's phenomenon.
The Journal of rheumatology 1994;21(1):80-3.
1994: Daniel O Clegg; James C Reading; MD Mayes; James R Seibold; C Harris; Fredrick M Wigley; J R Ward; E J Pisko; M H Weisman; P Lee
Comparison of aminobenzoate potassium and placebo in the treatment of scleroderma.
The Journal of rheumatology 1994;21(1):105-10.
1993: Fredrick M Wigley
Raynaud's phenomenon.
Current opinion in rheumatology 1993;5(6):773-84.
1993: WILLIAM SCOTT; Margaret Lethbridge-Cejku; R Reichle; Fredrick M Wigley; Jordan Tobin; Marc C Hochberg
Reliability of grading scales for individual radiographic features of osteoarthritis of the knee. The Baltimore longitudinal study of aging atlas of knee osteoarthritis.
Investigative radiology 1993;28(6):497-501.
1993: Ethylin Jabs; Cathy M Tuck-Muller; Grant J Anhalt; William C Earnshaw; Robert Wise; Fredrick M Wigley
Cytogenetic survey in systemic sclerosis: correlation of aneuploidy with the presence of anticentromere antibodies.
Cytogenetics and cell genetics 1993;63(3):169-75.
1992: Fredrick M Wigley
Treatment of systemic sclerosis.
Current opinion in rheumatology 1992;4(6):878-86.
1992: Fredrick M Wigley; James R Seibold; Robert Wise; D A McCloskey; W P Dole
Intravenous iloprost treatment of Raynaud's phenomenon and ischemic ulcers secondary to systemic sclerosis.
The Journal of rheumatology 1992;19(9):1407-14.
1992: S Blosser; Fredrick M Wigley; Robert Wise
Increase in translaryngeal resistance during phonation in rheumatoid arthritis.
Chest 1992;102(2):387-90.
1992: Fredrick M Wigley; Robert Wise; R Miller; B W Needleman; R J Spence
Anticentromere antibody as a predictor of digital ischemic loss in patients with systemic sclerosis.
Arthritis and rheumatism 1992;35(6):688-93.
1992: B W Needleman; Fredrick M Wigley; R W Stair
Interleukin-1, interleukin-2, interleukin-4, interleukin-6, tumor necrosis factor alpha, and interferon-gamma levels in sera from patients with scleroderma.
Arthritis and rheumatism 1992;35(1):67-72.
1991: Marc C Hochberg; Margaret Lethbridge-Cejku; C C Plato; Fredrick M Wigley; Jordan Tobin
Factors associated with osteoarthritis of the hand in males: data from the Baltimore Longitudinal Study of Aging.
American journal of epidemiology 1991;134(10):1121-7.
1991: Fredrick M Wigley
The differential diagnosis of Raynaud's phenomenon.
Hospital practice (Office ed.) 1991;26(7):63-70, 73-84.
1991: C A Thurm; Fredrick M Wigley; W P Dole; Robert Wise
Failure of vasoldilator infusion to alter pulmonary diffusing capacity in systemic sclerosis.
The American journal of medicine 1991;90(5):547-52.
1991: S L Wallace; J Z Singer; G J Duncan; Fredrick M Wigley; R W Kuncl
Renal function predicts colchicine toxicity: guidelines for the prophylactic use of colchicine in gout.
The Journal of rheumatology 1991;18(2):264-9.
1990: Fredrick M Wigley; Robert Wise; Jamal Mikdashi; S Schaefer; R J Spence
The post-occlusive hyperemic response in patients with systemic sclerosis.
Arthritis and rheumatism 1990;33(11):1620-5.
1990: D A Kallman; Fredrick M Wigley; WILLIAM SCOTT; Marc C Hochberg; Jordan Tobin
The longitudinal course of hand osteoarthritis in a male population.
Arthritis and rheumatism 1990;33(9):1323-32.
1989: D A Kallman; Fredrick M Wigley; WILLIAM SCOTT; Marc C Hochberg; Jordan Tobin
New radiographic grading scales for osteoarthritis of the hand. Reliability for determining prevalence and progression.
Arthritis and rheumatism 1989;32(12):1584-91.
1989: Joan M Bathon; David Proud; K Krackow; Fredrick M Wigley
Preincubation of human synovial cells with IL-1 modulates prostaglandin E2 release in response to bradykinin.
Journal of immunology (Baltimore, Md. : 1950) 1989;143(2):579-86.
1989: Joseph M Ahearn; J J Calomiris; Fredrick M Wigley; Douglas A Jabs; W B Bias; Marc C Hochberg
Characterization of the class I HLA 9.2-kb PVU II restriction fragment length polymorphism. Linkage to HLA-A and lack of disease association.
Arthritis and rheumatism 1989;32(7):870-6.
1989: William E Whitehead; G Taitelbaum; Fredrick M Wigley; Marvin M Schuster
Rectosigmoid motility and myoelectric activity in progressive systemic sclerosis.
Gastroenterology 1989;96(2 Pt 1):428-32.
1988: Robert Wise; Fredrick M Wigley; T E Scott; Marc C Hochberg
HLA-DQw alloantigens and pulmonary dysfunction in rheumatoid arthritis.
Chest 1988;94(3):609-14.
1988: J A Kopicky-Burd; Anne Kagey-Sobotka; Stephen P Peters; A M Dvorak; D W Lennox; Lawrence M Lichtenstein; Fredrick M Wigley
Characterization of human synovial mast cells.
The Journal of rheumatology 1988;15(9):1326-33.
1988: B G Katona; Fredrick M Wigley; J K Walters; M Caspi
Aseptic meningitis from over-the-counter ibuprofen.
Lancet 1988;1(8575-6):59.
1987: Fredrick M Wigley; R Malamet; Robert Wise
Reproducibility of cold provocation in patients with Raynaud's phenomenon.
The Journal of rheumatology 1987;14(4):751-5.
1987: J Z Livingston; T E Scott; Fredrick M Wigley; Grant J Anhalt; W B Bias; R H McLean; Marc C Hochberg
Systemic sclerosis (scleroderma): clinical, genetic, and serologic subsets.
The Journal of rheumatology 1987;14(3):512-8.
1987: T E Scott; Robert Wise; Marc C Hochberg; Fredrick M Wigley
HLA-DR4 and pulmonary dysfunction in rheumatoid arthritis.
The American journal of medicine 1987;82(4):765-71.
1987: Robert Wise; R Malamet; Fredrick M Wigley
Acute effects of nifedipine on digital blood flow in human subjects with Raynaud's phenomenon: a double blind placebo controlled trial.
The Journal of rheumatology 1987;14(2):278-83.
1987: Fredrick M Wigley; Robert Wise; R Malamet; T E Scott
Nicardipine in the treatment of Raynaud's phenomenon. Dissociation of platelet activation from vasospasm.
Arthritis and rheumatism 1987;30(3):281-6.
1986: M E Sanders; J A Kopicky; Fredrick M Wigley; Moon L Shin; M M Frank; K A Joiner
Membrane attack complex of complement in rheumatoid synovial tissue demonstrated by immunofluorescent microscopy.
The Journal of rheumatology 1986;13(6):1028-34.
1985: Marc Peters-Golden; Robert Wise; Marc C Hochberg; M B Stevens; Fredrick M Wigley
Incidence of lung cancer in systemic sclerosis.
The Journal of rheumatology 1985;12(6):1136-9.
1985: Robert Wise; Fredrick M Wigley; R Malamet
Digital pressure-flow relationships in subjects with Raynaud's phenomenon.
Angiology 1985;36(9):596-602.
1985: R Malamet; Robert Wise; W H Ettinger; Fredrick M Wigley
Nifedipine in the treatment of Raynaud's phenomenon. Evidence for inhibition of platelet activation.
The American journal of medicine 1985;78(4):602-8.
1984: Marc Peters-Golden; Robert Wise; Marc C Hochberg; M B Stevens; Fredrick M Wigley
Carbon monoxide diffusing capacity as predictor of outcome in systemic sclerosis.
The American journal of medicine 1984;77(6):1027-34.
1984: W H Ettinger; Robert Wise; D Schaffhauser; Fredrick M Wigley
Controlled double-blind trial of dazoxiben and nifedipine in the treatment of Raynaud's phenomenon.
The American journal of medicine 1984;77(3):451-6.
1984: Marc Peters-Golden; Robert Wise; P Schneider; Marc C Hochberg; M B Stevens; Fredrick M Wigley
Clinical and demographic predictors of loss of pulmonary function in systemic sclerosis.
Medicine 1984;63(4):221-31.
1984: Fredrick M Wigley
Osteoarthritis: practical management in older patients.
Geriatrics 1984;39(3):101-3, 106-7, 111-2, passim.
1983: W H Ettinger; Robert Wise; M B Stevens; Fredrick M Wigley
Absence of positional change in pulmonary diffusing capacity in systemic sclerosis.
The American journal of medicine 1983;75(2):305-12.
1983: Fredrick M Wigley; I T Fine; D S Newcombe
The role of the human synovial fibroblast in monosodium urate crystal-induced synovitis.
The Journal of rheumatology 1983;10(4):602-11.
1983: R J Rodeheffer; J A Rommer; Fredrick M Wigley; C R Smith
Controlled double-blind trial of nifedipine in the treatment of Raynaud's phenomenon.
The New England journal of medicine 1983;308(15):880-3.
1982: P D Schneider; Robert Wise; Marc C Hochberg; Fredrick M Wigley
Serial pulmonary function in systemic sclerosis.
The American journal of medicine 1982;73(3):385-94.
1982: Robert Wise; Fredrick M Wigley; H H Newball; M B Stevens
The effect of cold exposure on diffusing capacity in patients with Raynaud's phenomenon.
Chest 1982;81(6):695-8.
1982: Fredrick M Wigley
Rheumatoid arthritis II: systemic manifestations.
Maryland state medical journal 1982;31(5):40-2.
1980: J Chang; Fredrick M Wigley; D Newcombe
Neutral protease activation of peritoneal macrophage prostaglandin synthesis.
Proceedings of the National Academy of Sciences of the United States of America 1980;77(8):4736-40.
1978: J K Aronson; D G Grahame-Smith; Fredrick M Wigley
Monitoring digoxin therapy. The use of plasma digoxin concentration measurements in the diagnosis of digoxin toxicity.
The Quarterly journal of medicine 1978;47(186):111-22.
1976: H W Murray; Fredrick M Wigley; J J Mann; Ray Arthur
Combination antibiotic therapy in staphylococcal endocarditis. The use of methicillin sodium-gentamicin sulfate therapy.
Archives of internal medicine 1976;136(4):480-3.
1976: Fredrick M Wigley; H W Murray; R B Mann; G P Saba; H Kashima; J J Mann
Unusual manifestation of tuberculosis: TE fistula.
The American journal of medicine 1976;60(2):310-4.
1973: J E Salvaggio; R H Waldman; M H Fruchtman; Fredrick M Wigley; J E Johnson
Systemic and secretory antibody response of atopic and non-atopic individuals in intranasally administered tetanus toxoid.
Clinical allergy 1973;3(1):43-9.
1970: Fredrick M Wigley; M H Fruchtman; R H Waldman
Aerosol immunization of humans with inactivated parainfluenza type 2 vaccine.
The New England journal of medicine 1970;283(23):1250-3.
1969: Fredrick M Wigley; S H Wood; R H Waldman
Aerosol immunization of humans with tetanus toxoid.
Journal of immunology (Baltimore, Md. : 1950) 1969;103(5):1096-8.